NAVB

Navidea Biopharmaceuticals Inc.
NAVB

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

NAVB was delisted on the 5th of October, 2023.

Back to rankings

4 hedge funds and large institutions have $469 invested in Navidea Biopharmaceuticals Inc. in 2023 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

less funds holding

Funds holding: →

less first-time investments, than exits

New positions opened: | Existing positions closed:

less capital invested

Capital invested by funds: $ → $
Holders
4
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$435
2
+$14

Top Sellers

1
-$41.9K
2
-$37K
3
-$33.1K
4
VF
Virtu Financial
New York
-$30K
5
Vanguard Group
Vanguard Group
Pennsylvania
-$24.8K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$435
2
$19
3
$14
4
$1
5
–
6
–
7
–
8
–
9
–
10
–
11
–
12
–
13
–
14
–
15
–
16
–
17
–
18
–
19
–
20
–
21
–
22
–
23
–
24
–
25
–